[1]
S. Remya, M. J. Sudha, B. R. Nair, and K. L. Jayakumar, “A prospective comparative study of efficacy of lenalidomide plus dexamethasone combination therapy versus VAD (vincristine, doxorubicin and dexamethasone) regimen in the treatment of multiple myeloma”, Int J Basic Clin Pharmacol, vol. 6, no. 3, pp. 636–642, Feb. 2017.